🔴 First Tracks Biotherapeutics is trading 6.58% down today amid biotech selloff over hawkish Fed signals

First Tracks Biotherapeutics is trading 6.58% down now at $41.80, primarily amid a biotech-sector selloff linked to concerns that Federal Reserve Chair Kevin Warsh’s Jackson Hole remarks will keep monetary policy hawkish.

• No new company-specific announcement was identified for August 28, 2026.
• Biotech ETF XBI is down 2.31% as investors rotate away from higher-risk growth stocks.
• The latest company disclosures were its August 12 second-quarter results and September investor conferences.